Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RIGL
#2551
Rigel Pharmaceuticals, Inc. - Common Stock
46.8
6
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.82%
Monthly Change
+21.46%
6 month change
+37.95%
Year Change
+55.53%
Previous Close
46.4
8
Open
46.8
6
Low
46.8
6
High
46.8
6
Volume
43
Markets
US Stock Market
Healthcare
Biotechnology
RIGL
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2001
Quarterly report, Q2 FY2001
2001.08.14
RIGEL PHARMACEUTICALS INC quarterly report, Q2 FY2001
10-Q
Quarterly report, Q1 FY2001
2001.05.14
RIGEL PHARMACEUTICALS INC quarterly report, Q1 FY2001
10-Q
1
...
24
25
26
27
28
29
30
31
News
Rigel Pharmaceuticals: A Four-Drug Company With A Clinical Catalyst Ahead (NASDAQ:RIGL)
Rigel Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:RIGL) 2026-08-04
Rigel Pharmaceuticals, Inc. (RIGL) Q2 2026 Earnings Call Transcript
Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates
Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?
A Look At The Transformation Around Rigel Pharmaceuticals (NASDAQ:RIGL)
Rigel Pharmaceuticals, Inc. (RIGL) M&A Call - Slideshow (NASDAQ:RIGL) 2026-05-20
Rigel Pharmaceuticals, Inc. (RIGL) M&A Call Transcript
Arvinas: FDA Approval Validates The Platform, But Does Not Signal Near-Term Profitability
Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates
Rigel Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:RIGL) 2026-05-05
Guardian Pharmacy Services (GRDN) Reports Next Week: Wall Street Expects Earnings Growth